A retrospective alternative for active surveillance trials for ductal carcinoma in situ of the breast

Ductal carcinoma in situ (DCIS) of the breast is a nonobligate precursor of invasive breast cancer, accounting for 20 % of screen‐detected breast cancers. Little is known about the natural progression of DCIS because most patients undergo surgery upon diagnosis. Many DCIS patients are likely being o...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Bockstal, Mieke R., Agahozo, Marie C., Koppert, Linetta B., van Deurzen, Carolien H.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004157/
https://www.ncbi.nlm.nih.gov/pubmed/31018242
http://dx.doi.org/10.1002/ijc.32362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004157/
https://www.ncbi.nlm.nih.gov/pubmed/31018242
http://dx.doi.org/10.1002/ijc.32362

Ejemplares similares